Clinical Study
Retrospective Analysis on the Gallstone Disease after Gastrectomy for Gastric Cancer
Table 3
Surgical treatment for gallstone disease after gastrectomy.
| | Open cholecystectomy ( = 30) | Laparoscopic cholecystectomy ( = 29) | value |
| Age (year) | 62.3 ± 2.4 | 55.9 ± 2.2 | 0.048 | Gender | | | | Male | 21 (70) | 12 (44.8) | 0.077 | Female | 9 (30) | 16 (55.2) | | BMI (Kg/m2) | 22.6 ± 3.9 | 23.8 ± 3.0 | 0.204 | Interval between gastrectomy and detection of stones (month) | 49.5 ± 6.9 | 50.5 ± 7.8 | 0.918 | Type of gastrectomy | | | | Total gastrectomy | 14 (46.7) | 14 (48.3) | 0.612 | Subtotal gastrectomy | 16 (53.3) | 15 (51.7) | | Reconstruction | | | | Billroth I | 4 (13.3) | 5 (17.3) | 0.417 | Billroth II | 11 (36.7) | 7 (24.1) | Roux-en-Y | 15 (50) | 17 (58.6) | Indication of surgery | | | | Silent stone | 1 (3.3) | 11 (37.9) | 0.001 | Cholecystitis | 12 (40) | 14 (48.3) | CBD stone or cholangitis | 17 (56.7) | 4 (13.8) | Interval between detection of stones and cholecystectomy (month) | 11.7 ± 5.5 | 11.8 ± 3.2 | 0.936 | Operation | | | | Cholecystectomy | 9 (30) | 25 (86.2) | <0.001 | Cholecystectomy and choledochotomy | 21 (70) | 4 (13.8) | | Preoperative management | | | | PTBD before cholecystectomy | 1 (3.3) | 1 (3.4) | 0.981 | PTGBD before cholecystectomy | 2 (6.7) | 0 (0) | 0.157 | ERCP before cholecystectomy | 6 (20) | 2 (6.9) | 0.142 | Operation time (min) | 143 ± 8.8 | 82.7 ± 7.1 | <0.001 | EBL (mL) | 218.5 ± 26.5 | 140.2 ± 30.7 | 0.059 | Hospital stay (day) | 10 ± 0.6 | 3.9 ± 0.4 | <0.001 | Complications | 9 (30) | 0 (0) | 0.003 | Postoperative bile leak | 1 (3.3) | 0 (0) | Wound infection | 6 (20) | 0 (0) | Pulmonary | 2 (6.7) | 0 (0) |
|
|
PTBD = percutaneous transhepatic biliary drainage, PTGBD = percutaneous transhepatic gallbladder drainage, and ERCP = endoscopic retrograde cholangiopancreatography.
|